EARS News and Press, Auris Medical Holding AG From 05/13/19

Thinly traded Auris Medical ( EARS -14.9% ) slumps on triple normal volume, albeit on turnover of only 403K shares, on reaction to its public equity offering . More news on: Auris Medical Holding Ltd., Healthcare stocks news, Stocks on the move, Read more ...

INSYS Therapeutics (NASDAQ: INSY )  -51%  on potential bankruptcy . More news on: INSYS Therapeutics, Inc., Genetic Technologies Limited, Minerva Neurosciences, Inc., Stocks on the move, Read more ...

Hamilton, Bermuda, May 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, announced today the pricing of an unde...

Hamilton, Bermuda, May 07, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has reached th...

Gainers:  Diffusion Pharmaceuticals (NASDAQ: DFFN ) +49% . ARCA biopharma (NASDAQ: ABIO )  +47% . Digimarc Corporation (NASDAQ: DMRC ) +46% . Hudson Technologies (NASDAQ: HDSN ) +23% . InspireMD (NYSEMKT: NSPR ) +17% . Materion Corporation (NYSE: MTRN ) +16% . Precipio (NASD...

Gainers:  ARCA biopharma (NASDAQ: ABIO ) +37% . MFC Bancorp (NYSE: MFCB ) +32% . Enphase Energy (NASDAQ: ENPH ) +29% . Precipio (NASDAQ: PRPO ) +25% . Nu Skin Enterprises (NYSE: NUS ) +25% . Nanometrics Incorporated (NASDAQ: NANO ) +22% . Qumu Corporation (NASDAQ: QUMU ) +22% ....

Hamilton, Bermuda, April 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that its Board of Di...

Hamilton, Bermuda, April 25, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today provided an update on its tinn...

Hamilton, Bermuda, April 15, 2019 (GLOBE NEWSWIRE) -- Hamilton, Bermuda, April 15, 2019 – Auris Medical Holding Ltd. (Nasdaq: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous syste...

Auris Medical Holding (NASDAQ: EARS ) is 3.2% lower after hours as a holder files to offer up to 10M shares . More news on: Auris Medical Holding Ltd., Healthcare stocks news, Stocks on the move, Read more ...